EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Potential of Rosmarinus officinalis Extract on Endometriosis: Evidence from In Vitro Models

Sofía Del Valle, Ignacio Edgardo Ruiz Arias iD, Gustavo Leirós, Mariela Bilotas, Nancy Adriana Espinoza-Sánchez iD, Burkhard Greve, Martin Götte iD, Analía Ricci, Gabriela Meresman iD

International Journal of Molecular Sciences · 23.06.2026 · 27 (13) · 5654

DOI: 10.3390/ijms27135654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.06.2026. Verfasst von Sofía Del Valle und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Bueno…. Hauptthemen laut MEDLINE: Rosmarinus, Endometriosis, Plant Extracts. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación, Consejo Nacional de Investigaciones Científicas y Técnicas, EU H2020-MSCA-RISE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Natural therapeutic alternatives are increasingly explored in endometriosis, a highly prevalent gynecological disorder with limited therapeutic options. Rosmarinus officinalis (rosemary) has attracted increasing scientific interest due to its biological activity. This study aimed to characterize a hydroethanolic rosemary extract (RE) and evaluate its effects on key cellular processes involved in endometriosis pathophysiology. Major phenolic compounds in RE were quantified by RP-HPLC, and antioxidant activity was assessed using DPPH, ABTS, and FRAP assays. After RE treatment, cell viability (WST-1), migration (wound healing assay), cell cycle distribution (DAPI staining), apoptosis (Annexin V/PI), p21 and cyclin A expression (Western blot), and intracellular ROS levels (DCFH-DA) were evaluated in endometrial stromal (t-HESC, St-T1b) and endometriotic epithelial (12-Z) cells. Phytochemical analysis revealed rosmarinic acid (RA) at 4.2%, while carnosic acid (CA) and carnosol (CS) together accounted for 23.7% of the extract. RE reduced cell viability and cell migration in 12-Z and t-HESC cells (p < 0.05). S-phase accumulation with a concomitant reduction in the G1 phase was observed across all evaluated cell lines (p < 0.05), along with increased p21 and cyclin A expression in stromal cells (p < 0.05). RE induced cell death in both 12-Z (p < 0.05) and St-T1b cells (p < 0.0001). In t-HESC cells, RE reduced both basal and H2O2-induced ROS levels (p < 0.01). These findings indicate that RE modulates key mechanisms involved in endometriosis pathophysiology, supporting its multi-target therapeutic potential as a nutraceutical approach for endometriosis management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosmarinusEndometriosisPlant ExtractsFemaleHumansCell MovementCell SurvivalApoptosisAntioxidantsReactive Oxygen SpeciesCell LineAbietanesCell CycleRosmarinic AcidCell Proliferation

Stichwörter der Autor:innen

Rosmarinus officinaliscell migrationcell proliferationendometriosisoxidative stress

Substanzen

Plant ExtractsAntioxidantsReactive Oxygen SpeciescarnosolAbietanesRosmarinic Acid

Autor:innen und Institutionen

  • Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad Autónoma de Buenos Aires C1428ADN, Argentina.
  • Instituto de Investigación en Medicina y Ciencias de la Salud, Universidad del Salvador, Ciudad Autónoma de Buenos Aires C1055AAG, Argentina.
  • Instituto de Ciencia y Tecnología César Milstein, CONICET-Fundación Pablo Cassará, Ciudad Autónoma de Buenos Aires C1440FFX, Argentina.
  • Department of Radiation Oncology, Münster University Hospital, 48149 Münster, Germany.
  • Department of Gynecology and Obstetrics, Münster University Hospital, 48149 Münster, Germany.

ORCID-Profile: Ignacio Edgardo Ruiz Arias, Nancy Adriana Espinoza-Sánchez, Martin Götte, Gabriela Meresman

Förderung

  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • EU H2020-MSCA-RISE
  • BMBF
  • Universidad del Salvador
  • ANPCYT
  • CONICET
  • EU H2020-MSCA-RISE project TRENDO

Zitieren

APA

Del Valle, S., Ruiz Arias, I. E., Leirós, G., Bilotas, M., Espinoza-Sánchez, N. A., Greve, B., Götte, M., Ricci, A., & Meresman, G. (2026). Therapeutic Potential of Rosmarinus officinalis Extract on Endometriosis: Evidence from In Vitro Models. International Journal of Molecular Sciences, 27(13), 5654. https://doi.org/10.3390/ijms27135654

Vancouver

Del Valle S, Ruiz Arias IE, Leirós G, Bilotas M, Espinoza-Sánchez NA, Greve B, et al. Therapeutic Potential of Rosmarinus officinalis Extract on Endometriosis: Evidence from In Vitro Models. International Journal of Molecular Sciences. 2026;27(13):5654. doi:10.3390/ijms27135654

BibTeX
@article{DelValle2026,
  author = {Del Valle, Sofía and Ruiz Arias, Ignacio Edgardo and Leirós, Gustavo and Bilotas, Mariela and Espinoza-Sánchez, Nancy Adriana and Greve, Burkhard and Götte, Martin and Ricci, Analía and Meresman, Gabriela},
  title = {Therapeutic Potential of Rosmarinus officinalis Extract on Endometriosis: Evidence from In Vitro Models},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5654},
  doi = {10.3390/ijms27135654}
}
Kostenlos starten →